Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 13Lymphoma 8Lymphoma, Non-Hodgkin 7Recurrence 4Solid Tumor 3Melanoma 3Lymphoma, Large-Cell, Anaplastic 3Advanced Solid Tumors 3Solid Tumors 2Hodgkin Disease 2Hematologic Neoplasms 2Hematologic Diseases 2Carcinoma, Non-Small-Cell Lung 2Solid Tumours 1Solid Tumor, Adult 1Sarcoma, Synovial 1Sarcoma 1Rhabdoid Tumor 1Prostatic Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Mesothelioma 1Malignancies Multiple 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Carcinoma 1Advanced Solid Tumours 1Advanced Solid Tumor 1Advanced Solid Neoplasm 1Advanced Malignant Neoplasm 1

Interventions

pembrolizumab 11Injections 10tislelizumab 7Nivolumab 4Irinotecan 4Cetuximab 4cediranib 3Paclitaxel 3PM 01183 3Leucovorin 3Gemcitabine 3Fluorouracil 3Cisplatin 3toripalimab 2spartalizumab 2serabelisib 2olaparib 2glumetinib 2camrelizumab 2apatinib 2adagrasib 2Therapeutics 2Pemetrexed 2Oxaliplatin 2Midazolam 2Drug Therapy 2Docetaxel 2Digoxin 2Cyclophosphamide 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Advanced Solid Tumor × Rifampin × Clear all
NCT06198556 2024-02-28

Effect of Rifampicin on the Pharmacokinetics of HRS-1167 in Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
18 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡